Free Trial
NASDAQ:DRRX

DURECT (DRRX) Stock Price, News & Analysis

DURECT logo
$1.92 +0.02 (+1.05%)
As of 04:00 PM Eastern

About DURECT Stock (NASDAQ:DRRX)

Key Stats

Today's Range
$1.90
$1.94
50-Day Range
$0.52
$1.92
52-Week Range
$0.48
$2.64
Volume
416,978 shs
Average Volume
3.11 million shs
Market Capitalization
$59.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

DURECT Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

DRRX MarketRank™: 

DURECT scored higher than 45% of companies evaluated by MarketBeat, and ranked 727th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for DURECT are expected to decrease in the coming year, from ($0.50) to ($0.52) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DURECT is -19.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DURECT is -19.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DURECT has a P/B Ratio of 17.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.45% of the float of DURECT has been sold short.
  • Short Interest Ratio / Days to Cover

    DURECT has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in DURECT has recently decreased by 47.58%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    DURECT does not currently pay a dividend.

  • Dividend Growth

    DURECT does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.45% of the float of DURECT has been sold short.
  • Short Interest Ratio / Days to Cover

    DURECT has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in DURECT has recently decreased by 47.58%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    DURECT has a news sentiment score of 1.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for DURECT this week, compared to 1 article on an average week.
  • Search Interest

    6 people have searched for DRRX on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • MarketBeat Follows

    11 people have added DURECT to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DURECT insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.20% of the stock of DURECT is held by insiders.

  • Percentage Held by Institutions

    Only 28.03% of the stock of DURECT is held by institutions.

  • Read more about DURECT's insider trading history.
Receive DRRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DURECT and its competitors with MarketBeat's FREE daily newsletter.

DRRX Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.tc pixel
See More Headlines

DRRX Stock Analysis - Frequently Asked Questions

DURECT's stock was trading at $0.75 at the beginning of 2025. Since then, DRRX stock has increased by 156.0% and is now trading at $1.92.

DURECT Corporation (NASDAQ:DRRX) issued its earnings results on Tuesday, August, 12th. The specialty pharmaceutical company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. The specialty pharmaceutical company earned $0.45 million during the quarter, compared to analysts' expectations of $0.32 million. DURECT had a negative trailing twelve-month return on equity of 259.16% and a negative net margin of 96.19%.

Shares of DURECT reverse split on Tuesday, December 6th 2022.The 1-10 reverse split was announced on Tuesday, December 6th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, December 6th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

DURECT's top institutional shareholders include Richmond Brothers Inc. (4.68%), Ingalls & Snyder LLC (4.35%), Dalton Investments Inc. (2.40%) and Beirne Wealth Consulting Services LLC (1.01%).
View institutional ownership trends
.

Shares of DRRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DURECT investors own include CymaBay Therapeutics (CBAY), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), GE Aerospace (GE), Catalyst Pharmaceuticals (CPRX) and Pfizer (PFE).

Company Calendar

Last Earnings
8/12/2025
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:DRRX
CIK
1082038
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.32 million
Net Margins
-96.19%
Pretax Margin
-416.01%
Return on Equity
-259.16%
Return on Assets
-71.78%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.98
Quick Ratio
0.95

Sales & Book Value

Annual Sales
$2.03 million
Price / Sales
29.37
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.11 per share
Price / Book
17.45

Miscellaneous

Outstanding Shares
31,050,000
Free Float
30,060,000
Market Cap
$59.62 million
Optionable
Optionable
Beta
0.83
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:DRRX) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners